Department of Veterinary Pharmacology, Faculty of Agriculture, Tottori University, Tottori, Japan.
Department of Basic Sciences, Joint Graduate School of Veterinary Sciences, Tottori University, Tottori, Japan.
Fundam Clin Pharmacol. 2024 Dec;38(6):1178-1189. doi: 10.1111/fcp.13039. Epub 2024 Oct 17.
BACKGROUND/OBJECTIVES: Topically applied antifungal agents can induce adverse effects, such as pain and irritation. The transient receptor potential (TRP) channels-TRPA1 and TRPV1-mainly expressed in sensory neurons, act as sensors for detecting irritants. This study aims to evaluate the involvement of nociceptive channels in topical antifungal-induced pain and irritation. We tested nine topical antifungals belonging five classes: isoconazole, econazole, miconazole, clotrimazole, and ketoconazole as imidazoles; liranaftate as a thiocarbamate; terbinafine as an allylamine; amorolfine as a morpholine; and butenafine as a benzylamine.
Intracellular calcium concentrations ([Ca]) and membrane currents in response to antifungals were measured to estimate channel activity using heterologously expressing cells and isolated mouse sensory neurons.
In mouse TRPA1-expressing cells, all the tested drugs induced an increase in [Ca], which was abrogated or reduced by a TRPA1 blocker. Although many drugs evoked the TRPA1-nonspecific [Ca] response at high concentrations, responses to clotrimazole, ketoconazole, and liranaftate were TRPA1 specific and elicited current responses in TRPA1-expressing cells. In mouse TRPV1-expressing cells, clotrimazole and ketoconazole elicited [Ca] and current responses. In mouse sensory neurons, liranaftate-induced increase in [Ca] was abrogated by a TRPA1 blocker and Trpa1 deletion. Responses to ketoconazole were inhibited by TRPA1 and TRPV1 blockers and by the genetic deletion of either channel.
These results suggest that topical antifungal-induced pain and irritation are attributable to the activation of nociceptive TRPA1 and/or TRPV1 channel/s. Consequently, caution should be exercised in the use of topical antifungals with symptoms of pain.
背景/目的:局部应用的抗真菌药物可引起不良反应,如疼痛和刺激。瞬时受体电位(TRP)通道-TRPA1 和 TRPV1-主要表达在感觉神经元中,作为检测刺激物的传感器。本研究旨在评估伤害性通道在局部抗真菌诱导的疼痛和刺激中的作用。我们测试了属于五类的九种局部抗真菌药物:酮康唑、克霉唑、咪康唑、益康唑和酮康唑作为咪唑类;联苯苄唑作为硫代氨基甲酸酯;特比萘芬作为烯丙胺;阿莫罗芬作为吗啉;布替萘芬作为苄胺。
通过异源表达细胞和分离的小鼠感觉神经元测量细胞内钙浓度([Ca])和对抗真菌药物的膜电流,以估计通道活性。
在小鼠 TRPA1 表达细胞中,所有测试药物均诱导[Ca]增加,该增加被 TRPA1 阻断剂阻断或减少。尽管许多药物在高浓度下引起 TRPA1 非特异性[Ca]反应,但克霉唑、酮康唑和联苯苄唑的反应是 TRPA1 特异性的,并在 TRPA1 表达细胞中引起电流反应。在小鼠 TRPV1 表达细胞中,克霉唑和酮康唑引起[Ca]和电流反应。在小鼠感觉神经元中,联苯苄唑诱导的[Ca]增加被 TRPA1 阻断剂和 Trpa1 缺失所阻断。酮康唑的反应被 TRPA1 和 TRPV1 阻断剂以及两种通道的基因缺失所抑制。
这些结果表明,局部抗真菌诱导的疼痛和刺激归因于伤害性 TRPA1 和/或 TRPV1 通道的激活。因此,在出现疼痛症状时应谨慎使用局部抗真菌药物。